Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.

Diamond GA, Kaul S.

Am J Cardiol. 2007 Apr 1;99(7):1013-5. Epub 2007 Feb 15.

PMID:
17398203
2.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force.

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12. Review.

PMID:
16843744
3.

Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.

Reynolds TM.

J Tissue Viability. 2008 Nov;17(4):115-20. doi: 10.1016/j.jtv.2007.09.005. Epub 2008 Feb 20. Review.

PMID:
19061825
4.

Prevention and screening. Part II: Critical appraisal of articles on screening.

Soares I, Carneiro AV.

Rev Port Cardiol. 2003 Jan;22(1):117-30. Review. English, Portuguese.

6.

Early noninvasive identification of atherosclerosis: a new paradigm in preventive cardiology.

Rodgers GP, Beasley K, Ehrlich J.

Am Heart Hosp J. 2004 Winter;2(1):34-8. Review. No abstract available.

PMID:
15604837
7.

Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium.

Shaw LJ, Raggi P, Berman DS, Callister TQ.

Prog Cardiovasc Dis. 2003 Sep-Oct;46(2):171-84. Review.

PMID:
14505290
8.

Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.

Dennison CR, Hughes S.

J Cardiovasc Nurs. 2009 Jan-Feb;24(1):18-20. doi: 10.1097/01.JCN.0000343558.14237.70. Review. No abstract available.

PMID:
19114796
10.

Cardiovascular disease prevention tailored for women.

Engberding N, Wenger NK.

Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1123-34. doi: 10.1586/14779072.6.8.1123. Review.

PMID:
18793115
11.

Screening for disease, cost-effectiveness, and guidelines.

Meyer DL.

Prim Care. 1995 Dec;22(4):591-9. Review.

PMID:
8668731
12.

Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.

Lim LS, Hoeksema LJ, Sherin K; ACPM Prevention Practice Committee.

Am J Prev Med. 2009 Apr;36(4):366-75. doi: 10.1016/j.amepre.2009.01.013. Review.

PMID:
19285200
13.

Atherosclerosis imaging for risk assessment and primary prevention of cardiovascular disease.

Grundy SM.

Prog Cardiovasc Dis. 2003 Sep-Oct;46(2):115-21. Review.

PMID:
14505286
14.

Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence.

Ali R, Alexander KP.

Am J Geriatr Pharmacother. 2007 Mar;5(1):52-63. Review.

PMID:
17608248
15.

The cost effectiveness of preventing cardiovascular diseases.

Grover SA.

Can J Cardiol. 1999 Dec;15 Suppl G:114G-6G. Review. No abstract available.

PMID:
10692671
16.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

17.

[Atorvastatin in primary prevention].

Kültürsay H.

Turk Kardiyol Dern Ars. 2009 Mar;37 Suppl 2:17-22. Review. Turkish.

18.

Prevention of myocardial infarction.

Gurfinkel EP, Lernoud VS.

Curr Opin Cardiol. 2006 Sep;21(5):503-9. Review.

PMID:
16900015
19.

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U.

Eur J Public Health. 2009 Jun;19(3):245-53. doi: 10.1093/eurpub/ckp001. Epub 2009 Feb 5. Review.

PMID:
19196737

Supplemental Content

Support Center